Search research articles
Contact Us
Filters
Showing results (1-10 of 74) with videos related to
Page
of 8
Sort By:
Health Economics
|
December 14, 2006
Seeing for yourself: feasibility study towards valuing visual impairment using simulation spectacles
Samuel Aballéa, Aki Tsuchiya
Journal of Market Access & Health Policy
|
June 4, 2019
Measuring the health-related quality of life in young children: how far have we come?
Nicola Germain, Samuel Aballéa, Mondher Toumi
Public Health
|
September 5, 2021
The real-life impact of vaccination on COVID-19 mortality in Europe and Israel
Katarzyna Jabłońska, Samuel Aballéa, Mondher Toumi
Public Health
|
April 23, 2021
Factors influencing the COVID-19 daily deaths' peak across European countries
Katarzyna Jabłońska, Samuel Aballéa, Mondher Toumi
Journal of Market Access & Health Policy
|
March 27, 2026
Can We Trust PAICs in Rare Diseases? Methodological Challenges and Limitations
Mikolaj Parkitny, Samuel Aballéa, Piotr Wojciechowski, et al.
Journal of Market Access & Health Policy
|
November 18, 2021
On the association between SARS-COV-2 variants and COVID-19 mortality during the second wave of the pandemic in Europe
Katarzyna Jabłońska, Samuel Aballéa, Pascal Auquier, et al.
Psychiatry Research
|
December 3, 2015
Association between social contact frequency and negative symptoms, psychosocial functioning and quality of life in patients with schizophrenia
Karin Siegrist, Aurelie Millier, Ikbal Amri, et al.
Expert Review of Pharmacoeconomics & Outcomes Research
|
November 26, 2016
About the advantages and disadvantages of discrete-event simulation for health economic analyses
Mondher Toumi, Ekkehard Beck, Steve Sherman, et al.
Journal of Market Access & Health Policy
|
September 7, 2019
Systematic review of utility values used in the pharmacoeconomic evaluations for schizophrenia: implications on cost-effectiveness results
Junwen Zhou, Aurélie Millier, Clément François, et al.
Journal of Market Access & Health Policy
|
April 25, 2025
Clinical Trial Validity Guidance from the HTACG: Looking for Chicken Teeth
Mondher Toumi, Bruno Falissard, Asma Jouini, et al.
Page
of 8
Search research articles
Search
Showing results (1-10 of 74) with videos related to
Sort By:
Page
of 8
Health Economics
|
December 14, 2006
Seeing for yourself: feasibility study towards valuing visual impairment using simulation spectacles
Samuel Aballéa, Aki Tsuchiya
Journal of Market Access & Health Policy
|
June 4, 2019
Measuring the health-related quality of life in young children: how far have we come?
Nicola Germain, Samuel Aballéa, Mondher Toumi
Public Health
|
September 5, 2021
The real-life impact of vaccination on COVID-19 mortality in Europe and Israel
Katarzyna Jabłońska, Samuel Aballéa, Mondher Toumi
Public Health
|
April 23, 2021
Factors influencing the COVID-19 daily deaths' peak across European countries
Katarzyna Jabłońska, Samuel Aballéa, Mondher Toumi
Journal of Market Access & Health Policy
|
March 27, 2026
Can We Trust PAICs in Rare Diseases? Methodological Challenges and Limitations
Mikolaj Parkitny, Samuel Aballéa, Piotr Wojciechowski, et al.
Journal of Market Access & Health Policy
|
November 18, 2021
On the association between SARS-COV-2 variants and COVID-19 mortality during the second wave of the pandemic in Europe
Katarzyna Jabłońska, Samuel Aballéa, Pascal Auquier, et al.
Psychiatry Research
|
December 3, 2015
Association between social contact frequency and negative symptoms, psychosocial functioning and quality of life in patients with schizophrenia
Karin Siegrist, Aurelie Millier, Ikbal Amri, et al.
Expert Review of Pharmacoeconomics & Outcomes Research
|
November 26, 2016
About the advantages and disadvantages of discrete-event simulation for health economic analyses
Mondher Toumi, Ekkehard Beck, Steve Sherman, et al.
Journal of Market Access & Health Policy
|
September 7, 2019
Systematic review of utility values used in the pharmacoeconomic evaluations for schizophrenia: implications on cost-effectiveness results
Junwen Zhou, Aurélie Millier, Clément François, et al.
Journal of Market Access & Health Policy
|
April 25, 2025
Clinical Trial Validity Guidance from the HTACG: Looking for Chicken Teeth
Mondher Toumi, Bruno Falissard, Asma Jouini, et al.
Page
of 8